EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

TcMAC21 mouse model recapitulates abnormal vascular physiology observed in humans with Down syndrome

Xiangyu Zheng, Mostafa Sabouri, Bryan J Irwin, Joseph Bernardo, Daniel R Machin iD

Physiological Reports · 2025

DOI: 10.14814/phy2.70384 ↗

At a glance

Journal article in Physiological Reports, 2025. Written by Xiangyu Zheng and 4 co-authors. Institution: Department of Nutrition and Integrative Physiology, Florida State University, Tallahassee, Florida, USA. Major MEDLINE topics: Down Syndrome, Vascular Stiffness, Endothelium, Vascular. Cited 4 times so far (Crossref); 106 references. The full text is freely available (open access, CC BY 4.0). Funded by: NCCIH NIH HHS, National Center for Complementary and Integrative Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

People with Down syndrome (DS) have abnormal vascular physiology, demonstrated by low systolic blood pressure (BP) and low aortic stiffness that are accompanied by endothelial dysfunction. The TcMAC21 mouse model of DS has many features observed in people with DS, although vascular physiology has not been studied. At 4 months old, male and female TcMAC21 mice exhibited lower systolic BP and aortic stiffness, as determined by aortic pulse wave velocity, which are accompanied by blunted carotid artery flow‐mediated vasodilation, indicating endothelial dysfunction, compared to euploid (i.e., control) mice. To determine a potential mechanism for blunted flow‐mediated vasodilation, we assessed endothelial glycocalyx properties, which mechanotransduces fluid shear stress to the endothelial cells, stimulating flow‐mediated vasodilation. We observed a lower glycocalyx thickness in the mesenteric microcirculation of TcMAC21 mice. Vascular abnormalities in TcMAC21 mice were accompanied by systemic inflammation. This is the first study to examine vascular physiology in the TcMAC21 mouse model of DS and investigate glycocalyx properties in any model of DS, including humans. Taken together, these findings support the use of the TcMAC21 mouse model to study the vascular physiology in people with DS and may provide translational insight into the role of glycocalyx in vascular abnormalities in DS.

Subjects

MeSH terms (MEDLINE)

Down SyndromeVascular StiffnessEndothelium, VascularAnimalsMaleDisease Models, AnimalFemaleMiceGlycocalyxVasodilationBlood PressureMice, Inbred C57BL

Author keywords

aortic stiffnessblood pressureendotheliumglycocalyxtrisomy 21

Authors and institutions

  • Department of Nutrition and Integrative Physiology, Florida State University, Tallahassee, Florida, USA.
  • Cardiology Division, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Vascular Physiology Group, Department of Cell Biology and Physiology, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
  • Department of Biological Science, Florida State University, Tallahassee, Florida, USA.

ORCID profiles: Daniel R Machin

Funding

  • NCCIH NIH HHS
  • National Center for Complementary and Integrative Health

Cite

APA

Zheng, X., Sabouri, M., Irwin, B. J., Bernardo, J., & Machin, D. R. (2025). TcMAC21 mouse model recapitulates abnormal vascular physiology observed in humans with Down syndrome. Physiological Reports. https://doi.org/10.14814/phy2.70384

Vancouver

Zheng X, Sabouri M, Irwin BJ, Bernardo J, Machin DR. TcMAC21 mouse model recapitulates abnormal vascular physiology observed in humans with Down syndrome. Physiological Reports. 2025. doi:10.14814/phy2.70384

BibTeX
@article{Zheng2025,
  author = {Zheng, Xiangyu and Sabouri, Mostafa and Irwin, Bryan J and Bernardo, Joseph and Machin, Daniel R},
  title = {TcMAC21 mouse model recapitulates abnormal vascular physiology observed in humans with Down syndrome},
  journal = {Physiological Reports},
  year = {2025},
  doi = {10.14814/phy2.70384}
}
Start for free →